NCT05610397View on ClinicalTrials.gov

Retrospective Study With Patients Treated With STALIF® C or M and Ti or FLX Implants for 1 and 2 Levels

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

April 24, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

September 30, 2024

Conditions
Degenerative Disc DiseaseGrade 1 SpondylolisthesisRetrolisthesisSymptomatic Cervical Disc Disease
Interventions
DEVICE

STALIF®

STALIF® C, or M, Ti or FLX

Sponsors

Lead Sponsor

Centinel Spine
All Listed Sponsors
lead

Centinel Spine

INDUSTRY